288 related articles for article (PubMed ID: 33014530)
1. Roles of Biomarkers in Myocardial Fibrosis.
Ding Y; Wang Y; Zhang W; Jia Q; Wang X; Li Y; Lv S; Zhang J
Aging Dis; 2020 Oct; 11(5):1157-1174. PubMed ID: 33014530
[TBL] [Abstract][Full Text] [Related]
2. Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.
López B; González A; Ravassa S; Beaumont J; Moreno MU; San José G; Querejeta R; Díez J
J Am Coll Cardiol; 2015 Jun; 65(22):2449-56. PubMed ID: 26046739
[TBL] [Abstract][Full Text] [Related]
3. Influence of acute or chronic rejection on myocardial collagen density in serial endomyocardial biopsy specimens from cardiac allografts.
Fornes P; Heudes D; Simon D; Guillemain R; Amrein C; Bruneval P
J Heart Lung Transplant; 1996 Aug; 15(8):796-803. PubMed ID: 8878762
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
Flett AS; Hayward MP; Ashworth MT; Hansen MS; Taylor AM; Elliott PM; McGregor C; Moon JC
Circulation; 2010 Jul; 122(2):138-44. PubMed ID: 20585010
[TBL] [Abstract][Full Text] [Related]
5. Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.
Barison A; Grigoratos C; Todiere G; Aquaro GD
Heart Fail Rev; 2015 Nov; 20(6):731-49. PubMed ID: 26423909
[TBL] [Abstract][Full Text] [Related]
6. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
[TBL] [Abstract][Full Text] [Related]
7. Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels.
Babür Güler G; Karaahmet T; Tigen K
Anadolu Kardiyol Derg; 2011 Feb; 11(1):71-6. PubMed ID: 21220243
[TBL] [Abstract][Full Text] [Related]
8. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
11. CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation.
Lurz JA; Luecke C; Lang D; Besler C; Rommel KP; Klingel K; Kandolf R; Adams V; Schöne K; Hindricks G; Schuler G; Linke A; Thiele H; Gutberlet M; Lurz P
JACC Cardiovasc Imaging; 2018 Jan; 11(1):38-45. PubMed ID: 28412435
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
[TBL] [Abstract][Full Text] [Related]
13. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.
Díez J; Querejeta R; López B; González A; Larman M; Martínez Ubago JL
Circulation; 2002 May; 105(21):2512-7. PubMed ID: 12034658
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of myocardial fibrosis.
de Jong S; van Veen TA; de Bakker JM; Vos MA; van Rijen HV
J Cardiovasc Pharmacol; 2011 May; 57(5):522-35. PubMed ID: 21423029
[TBL] [Abstract][Full Text] [Related]
15. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.
Querejeta R; Varo N; López B; Larman M; Artiñano E; Etayo JC; Martínez Ubago JL; Gutierrez-Stampa M; Emparanza JI; Gil MJ; Monreal I; Mindán JP; Díez J
Circulation; 2000 Apr; 101(14):1729-35. PubMed ID: 10758057
[TBL] [Abstract][Full Text] [Related]
16. The role of storage of interstitial myocardial collagen on the overlife rate of patients with idiopathic and Chagasic dilated cardiomyopathy.
Nunes VL; Ramires FJ; Pimentel Wde S; Fernandes F; Ianni BM; Mady C
Arq Bras Cardiol; 2006 Dec; 87(6):757-62. PubMed ID: 17262114
[TBL] [Abstract][Full Text] [Related]
17. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy.
Ellims AH; Taylor AJ; Mariani JA; Ling LH; Iles LM; Maeder MT; Kaye DM
Circ Heart Fail; 2014 Mar; 7(2):271-8. PubMed ID: 24481111
[TBL] [Abstract][Full Text] [Related]
19. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY
Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive assessment of liver fibrosis: key messages for clinicians.
Caviglia GP; Touscoz GA; Smedile A; Pellicano R
Pol Arch Med Wewn; 2014; 124(6):329-35. PubMed ID: 24781707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
